Worg Pharmaceuticals

About:

Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergies and other diseases.

Website: http://www.worgpharma.com/

Top Investors: DT Capital Partners, Puhua Capital, Kaitai Capital, Junson Capital, Shanghai Bairun Investment Holding Group

Description:

Worg Pharmaceuticals is a clinical-stage biopharmaceutical company developing new treatments for allergies and other diseases. The company is building a pipeline for allergy and autoimmune diseases based on two technology platforms, PCFiT and Apitope, through internal development and external collaboration with flexible business models. Worg is also developing a platform for molecular allergy diagnosis.

Total Funding Amount:

1.7B CNY

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2018-01-01

Contact Email:

info(AT)worgpharma.com

Founders:

Andrew Xu

Number of Employees:

11-50

Last Funding Date:

2023-06-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai